Waypoint Capital Advisors’s NeoGenomics NEO Stock Holding History

Waypoint Capital Advisors’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-20,855	Closed	-$335K	–	125
2023 Q2	$335K	Hold	20,855	–	–	0.1%	105
2023 Q1	$363K	Hold	20,855	–	–	0.12%	101
2022 Q4	$193K	Buy	+20,855	New	+$194K	0.07%	126
2022 Q2	–	Sell	-21,422	Closed	-$285K	–	130
2022 Q1	$285K	Buy	+21,422	New	+$451K	0.17%	95

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Waypoint Capital Advisors's NEO Position: Q3 2023 in Review

Waypoint Capital Advisors sold out of NeoGenomics (NEO) in Q3 2023, closing a stake of 20,855 shares — an estimated $335K sold.

Waypoint Capital Advisors first reported a position in NEO in Q1 2022 and held it in 4 quarters. The position peaked at $363K in Q1 2023. 283 funds tracked by Wall St. Rank hold NEO as of Q3 2023.

Waypoint Capital Advisors reported no remaining NeoGenomics position as of Q3 2023 after selling out during the quarter.
Waypoint Capital Advisors sold 20,855 NeoGenomics shares in Q3 2023, an estimated $335K.
Waypoint Capital Advisors first reported a position in NeoGenomics in Q1 2022 and held it in 4 quarters.
Waypoint Capital Advisors's NeoGenomics position peaked at $363K in Q1 2023.
283 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2023.

Based on Waypoint Capital Advisors's 13F filing for Q3 2023, filed 25 Oct 2023.